Literature DB >> 21389326

Structural insights into the extracellular assembly of the hematopoietic Flt3 signaling complex.

Kenneth Verstraete1, Gonzalez Vandriessche, Mariska Januar, Jonathan Elegheert, Alexander V Shkumatov, Ambroise Desfosses, Kathleen Van Craenenbroeck, Dmitri I Svergun, Irina Gutsche, Bjorn Vergauwen, Savvas N Savvides.   

Abstract

The class III receptor tyrosine kinase (RTKIII) Fms-like tyrosine kinase receptor 3 (Flt3) and its cytokine ligand (FL) play central roles in hematopoiesis and the immune system, by establishing signaling cascades crucial for the development and homeostasis of hematopoietic progenitors and antigen-presenting dendritic cells. However, Flt3 is also one of the most frequently mutated receptors in hematologic malignancies and is currently a major prognostic factor and clinical target for acute myeloid leukemia. Here, we report the structural basis for the Flt3 ligand-receptor complex and unveil an unanticipated extracellular assembly unlike any other RTKIII/V complex characterized to date. FL induces dimerization of Flt3 via a remarkably compact binding epitope localized at the tip of extracellular domain 3 of Flt3, and it invokes a ternary complex devoid of homotypic receptor interactions. Comparisons of Flt3 with homologous receptors and available mutagenesis data for FL have allowed us to rationalize the unique features of the Flt3 extracellular assembly. Furthermore, thermodynamic dissection of complex formation points to a pronounced enthalpically driven binding event coupled to an entropic penalty. Together, our data suggest that the high-affinity Flt3:FL complex is driven in part by a single preformed binding epitope on FL reminiscent of a "lock-and-key" binding mode, thereby setting the stage for antagonist design.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21389326     DOI: 10.1182/blood-2011-01-329532

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

1.  Allogeneic FLT3 CAR T Cells with an Off-Switch Exhibit Potent Activity against AML and Can Be Depleted to Expedite Bone Marrow Recovery.

Authors:  Cesar Sommer; Hsin-Yuan Cheng; Duy Nguyen; Danielle Dettling; Yik Andy Yeung; Janette Sutton; Moustafa Hamze; Julien Valton; Julianne Smith; Ivana Djuretic; Javier Chaparro-Riggers; Barbra J Sasu
Journal:  Mol Ther       Date:  2020-06-19       Impact factor: 11.454

2.  Insights into the molecular activation mechanism of the RhoA-specific guanine nucleotide exchange factor, PDZRhoGEF.

Authors:  Jakub A Bielnicki; Alexander V Shkumatov; Urszula Derewenda; Avril V Somlyo; Dmitri I Svergun; Zygmunt S Derewenda
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

3.  An Optimized Full-Length FLT3/CD3 Bispecific Antibody Demonstrates Potent Anti-leukemia Activity and Reversible Hematological Toxicity.

Authors:  Yik Andy Yeung; Veena Krishnamoorthy; Danielle Dettling; Cesar Sommer; Kris Poulsen; Irene Ni; Amber Pham; Wei Chen; Sindy Liao-Chan; Kevin Lindquist; S Michael Chin; Allison Given Chunyk; Wenyue Hu; Barbra Sasu; Javier Chaparro-Riggers; Ivana Djuretic
Journal:  Mol Ther       Date:  2020-01-14       Impact factor: 11.454

Review 4.  Extracellular assembly and activation principles of oncogenic class III receptor tyrosine kinases.

Authors:  Kenneth Verstraete; Savvas N Savvides
Journal:  Nat Rev Cancer       Date:  2012-10-18       Impact factor: 60.716

5.  Oligomerization propensity and flexibility of yeast frataxin studied by X-ray crystallography and small-angle X-ray scattering.

Authors:  Christopher A G Söderberg; Alexander V Shkumatov; Sreekanth Rajan; Oleksandr Gakh; Dmitri I Svergun; Grazia Isaya; Salam Al-Karadaghi
Journal:  J Mol Biol       Date:  2011-10-25       Impact factor: 5.469

6.  Structure of Full-Length Human PDGFRβ Bound to Its Activating Ligand PDGF-B as Determined by Negative-Stain Electron Microscopy.

Authors:  Po-Han Chen; Vinzenz Unger; Xiaolin He
Journal:  J Mol Biol       Date:  2015-10-20       Impact factor: 5.469

7.  Multipronged attenuation of macrophage-colony stimulating factor signaling by Epstein-Barr virus BARF1.

Authors:  Ann Hye-Ryong Shim; Rhoda Ahn Chang; Xiaoyan Chen; Richard Longnecker; Xiaolin He
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-23       Impact factor: 11.205

Review 8.  More than the sum of the parts: Toward full-length receptor tyrosine kinase structures.

Authors:  Devan Diwanji; Tarjani Thaker; Natalia Jura
Journal:  IUBMB Life       Date:  2019-05-02       Impact factor: 3.885

9.  Development and Characterization of FLT3-Specific Curcumin-Loaded Polymeric Micelles as a Drug Delivery System for Treating FLT3-Overexpressing Leukemic Cells.

Authors:  Singkome Tima; Siriporn Okonogi; Chadarat Ampasavate; Chad Pickens; Cory Berkland; Songyot Anuchapreeda
Journal:  J Pharm Sci       Date:  2016-10-14       Impact factor: 3.534

10.  Allosteric competitive inactivation of hematopoietic CSF-1 signaling by the viral decoy receptor BARF1.

Authors:  Jonathan Elegheert; Nathalie Bracke; Philippe Pouliot; Irina Gutsche; Alexander V Shkumatov; Nicolas Tarbouriech; Kenneth Verstraete; Anaïs Bekaert; Wim P Burmeister; Dmitri I Svergun; Bart N Lambrecht; Bjorn Vergauwen; Savvas N Savvides
Journal:  Nat Struct Mol Biol       Date:  2012-08-19       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.